Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabis and anticancer drugs: societal usage and expected pharmacological interactions – a review
Régis Bouquié, Guillaume Deslandes, Hélène Mazaré, et al.
Fundamental and Clinical Pharmacology (2018) Vol. 32, Iss. 5, pp. 462-484
Closed Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

ASRA Pain Medicine consensus guidelines on the management of the perioperative patient on cannabis and cannabinoids
Shalini Shah, Eric S. Schwenk, Rakesh V. Sondekoppam, et al.
Regional Anesthesia & Pain Medicine (2023) Vol. 48, Iss. 3, pp. 97-117
Open Access | Times Cited: 58
Medicinal Cannabis—Potential Drug Interactions
Indeewarie Hemamali Dissanayake, Chun Guang Li
Medicines (2018) Vol. 6, Iss. 1, pp. 3-3
Open Access | Times Cited: 150
Future Aspects for Cannabinoids in Breast Cancer Therapy
Terézia Kisková, Felicitas Mungenast, Mária Suváková, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 7, pp. 1673-1673
Open Access | Times Cited: 118
Cannabis and Cannabinoids: Kinetics and Interactions
Brian C. Foster, Hanan Abramovici, Cory S. Harris
The American Journal of Medicine (2019) Vol. 132, Iss. 11, pp. 1266-1270
Closed Access | Times Cited: 88
Opportunities for cannabis in supportive care in cancer
Amber S. Kleckner, Ian R. Kleckner, Charles Kamen, et al.
Therapeutic Advances in Medical Oncology (2019) Vol. 11
Open Access | Times Cited: 82
It Is Our Turn to Get Cannabis High: Put Cannabinoids in Food and Health Baskets
Seyed Alireza Salami, Federico Martinelli, Antonio Giovino, et al.
Molecules (2020) Vol. 25, Iss. 18, pp. 4036-4036
Open Access | Times Cited: 71
Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions
Paul T. Kocis, Kent E. Vrana
Medical Cannabis and Cannabinoids (2020) Vol. 3, Iss. 1, pp. 61-73
Open Access | Times Cited: 58
Potential, Limitations and Risks of Cannabis-Derived Products in Cancer Treatment
Herman J. Woerdenbag, Peter Olinga, Ellen A. Kok, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 2119-2119
Open Access | Times Cited: 17
Herb-anticancer drug interactions in real life based on VigiBase, the WHO global database
Stéphanie Pochet, Anne-Sophie Lechon, Cécile Lescrainier, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 21
Consumer Contribution in Designing Medicinal Cannabis Clinical Trials in Palliative Medicine
Valentina Razmovski‐Naumovski, Beverly Noble, Linda Brown, et al.
Journal of Palliative Medicine (2025)
Closed Access
Drug interactions of tetrahydrocannabinol and cannabidiol in cannabinoid drugs
Thomas Herdegen, Ingolf Cascorbi
Deutsches Ärzteblatt international (2023)
Open Access | Times Cited: 9
Cannabis‐infused foods: Phytonutrients, health, and safe product innovations
Eric Fordjour, Charles F. Manful, Tarsaim S. K. Khalsamehta, et al.
Comprehensive Reviews in Food Science and Food Safety (2024) Vol. 23, Iss. 5
Open Access | Times Cited: 3
Cannabis Use among Cancer Survivors: Use Pattern, Product Type, and Timing of Use
Ikponmwosa Osaghae, Onyema Greg Chido‐Amajuoyi, Banda A. A. Khalifa, et al.
Cancers (2023) Vol. 15, Iss. 24, pp. 5822-5822
Open Access | Times Cited: 6
Medicinal Cannabis - Potential Drug Interactions
Muhammad A. Alsherbiny, Chun G. Li
(2018)
Open Access | Times Cited: 18
Effects of concomitant use of THC and irinotecan on tumour growth and biochemical markers in a syngeneic mouse model of colon cancer
Suzana Žunec, Irena Brčić Karačonji, Martin Čatalinac, et al.
Archives of Industrial Hygiene and Toxicology (2023) Vol. 74, Iss. 3, pp. 198-206
Open Access | Times Cited: 5
Prevalence, reasons for use, perceived benefits, and awareness of health risks of cannabis use among cancer survivors – implications for policy and interventions
Ikponmwosa Osaghae, Onyema Greg Chido‐Amajuoyi, Rajesh Talluri, et al.
Journal of Cancer Survivorship (2023)
Closed Access | Times Cited: 5
The Potential Clinical Implications and Importance of Drug Interactions Between Anticancer Agents and Cannabidiol in Patients With Cancer
B Opitz, Marissa L. Ostroff, Arin Whitman
Journal of Pharmacy Practice (2019) Vol. 33, Iss. 4, pp. 506-512
Closed Access | Times Cited: 15
Medical cannabis use among individuals with cancer: An unresolved and timely issue
Shannon M. Nugent, Salimah H. Meghani, Shari S. Rogal, et al.
Cancer (2020) Vol. 126, Iss. 9, pp. 1832-1836
Open Access | Times Cited: 13
The curative effect of cannabinoid 2 receptor agonist on functional failure and disruptive inflammation caused by intestinal ischemia and reperfusion
Sait Bayram, Ali Parlar, Seyfullah Oktay Arslan
Fundamental and Clinical Pharmacology (2019) Vol. 34, Iss. 1, pp. 80-90
Open Access | Times Cited: 12
Cannabinoid consumption among cancer patients receiving systemic anti-cancer treatment in the Netherlands
Yrina Oelen, Sven Revenberg, Judith de Vos‐Geelen, et al.
Journal of Cancer Research and Clinical Oncology (2022) Vol. 149, Iss. 5, pp. 1863-1872
Open Access | Times Cited: 6
Cannabinoids-based Medicine Pharmacology, Drug Interactions, and Perioperative Management of Surgical Patients
Samer Narouze, Natalie Strand, Priodarshi Roychoudhury
Advances in Anesthesia (2020) Vol. 38, pp. 167-188
Closed Access | Times Cited: 4
Wohlbefinden
Jamie Peyton, Katherine J. Kramer, Brook Quesnell, et al.
(2024), pp. 187-211
Closed Access
A Pediatric Hospital Policy for Medical Marijuana Use
Amy E. Carver, Jennifer Jorgensen, Michael Barberio, et al.
PEDIATRICS (2020) Vol. 146, Iss. 2
Open Access | Times Cited: 3
First Attempt to Couple Proteomics with the AhR Reporter Gene Bioassay in Soil Pollution Monitoring and Assessment
Claudia Landi, Giulia Liberatori, Pietro Cotugno, et al.
Toxics (2021) Vol. 10, Iss. 1, pp. 9-9
Open Access | Times Cited: 3
High Doses of Δ9-Tetrahydrocannabinol Might Impair Irinotecan Chemotherapy: A Review of Potentially Harmful Interactions
Nevenka Kopjar, Nino Fuchs, Irena Brčić Karačonji, et al.
Clinical Drug Investigation (2020) Vol. 40, Iss. 9, pp. 775-787
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top